about
Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumoursHyperbaric oxygen modalities are differentially effective in distinct brain ischemia modelsNeuroprotective effect of hyperbaric oxygen in a rat model of subarachnoid hemorrhage.Serum leptin levels decrease after permanent MCAo in the rat and remain unaffected by delayed hyperbaric oxygen therapyCyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury.Maternal hypoxia increases the activity of MMPs and decreases the expression of TIMPs in the brain of neonatal ratsActivation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaBBrain irradiation improves focal cerebral ischemia recovery in aged rats.Isoflurane posttreatment reduces brain injury after an intracerebral hemorrhagic stroke in mice.Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhageMolecular mechanisms of early brain injury after subarachnoid hemorrhage.Delayed hyperbaric oxygen therapy induces cell proliferation through stabilization of cAMP responsive element binding protein in the rat model of MCAo-induced ischemic brain injuryBeneficial effect of hyperbaric oxygenation after neonatal germinal matrix hemorrhage.The postpartum period of pregnancy worsens brain injury and functional outcome after cerebellar hemorrhage in rats.Role of the pituitary–adrenal axis in granulocyte-colony stimulating factor-induced neuroprotection against hypoxia–ischemia in neonatal ratsThe pacific chapter annual meeting of the undersea & hyperbaric medical society.Targeting C/EBP homologous protein with siRNA attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.The efficacy of hyperbaric oxygen in hemorrhagic stroke: experimental and clinical implications.The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemiaIsoflurane on brain inflammation.Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats.Commentary on: "Effect of sevoflurane anesthesia on the comprehensive mRNA expression profile of the mouse hippocampus": Postoperative nausea and vomiting conundrum: RNA-seq to the rescue.Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury.Suppression of hypoxia-inducible factor-1alpha and its downstream genes reduces acute hyperglycemia-enhanced hemorrhagic transformation in a rat model of cerebral ischemia.Hydrogen inhalation is neuroprotective and improves functional outcomes in mice after intracerebral hemorrhage.FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice.Hydrogen gas is ineffective in moderate and severe neonatal hypoxia-ischemia rat models.Effects of apocynin and ethanol on intracerebral haemorrhage-induced brain injury in rats.Normoxic induction of cerebral HIF-1alpha by acetazolamide in rats: role of acidosis.Effect of amantadine sulphate on intracerebral hemorrhage-induced brain injury in rats.Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage.Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1alpha and erythropoietin in rats.Evaluation of morphological changes after treatment with coenzyme Q10 (CoQ10) in endothelin-1 induced experimental ischemia in the rat.Hyperbaric oxygen preconditioning reduces postoperative brain edema and improves neurological outcomes after surgical brain injury.Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen.Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model.Hyperbaric oxygen for neurologic indications--action plan for multicenter trials in: stroke, traumatic brain injury, radiation encephalopathy & status migrainosus.Effect of coenzyme Q(10) on biochemical and morphological changes in experimental ischemia in the rat brain.Potent Antitumour Effects of Novel Pentabromobenzylisothioureas Studied on Human Glial-derived Tumour Cell Lines.
P50
Q26739908-8B2D36FC-9FC6-4B8B-A276-7D3C290A35E8Q28068754-2457F04B-CC00-47F9-A8F9-39E7E4DE114CQ33242054-5BE4704C-C104-4220-B1FF-F90B2E7DEFFFQ33457432-7BD47542-815C-43EE-AB9F-20C45B4B737BQ33598777-B2C4E255-D47A-43DA-B46A-C5F48A766C84Q33642536-936C640C-E38F-466C-AEF4-44B9AFCC7658Q33708001-B93B3105-FEF6-49B0-82FC-A54EEE014399Q33868518-E73295B2-DEB3-4BCE-8A3E-F577F4854ABBQ33906540-ACE8B42E-F076-4AB8-B7A7-37C77B9E2CB6Q35216123-A51509EF-8B53-4827-9C1D-5E869A79D5AEQ36499334-5B617B63-3A0A-4359-9BA1-B3F6F968F111Q36569490-C0AA267C-02E2-48D0-AC1E-AA7BB0B3CE3BQ36600499-66A217AE-E617-4A94-9EC2-46EB70416F72Q36600511-23655E4F-26C8-4DD6-920E-DE9441DEE83CQ36709806-157D6979-C549-4051-896F-3F5071895409Q39639036-8CA79246-BA1E-4EE6-A5AF-ED32CB9FBACFQ41141355-B6A72308-F54F-431E-A4E7-A84C6DDD6A51Q41549601-481F8ED9-60AD-4A57-AA5B-541F8962B7B6Q41839825-E00FA255-FD33-4CEE-B6F1-7D380C208D97Q41941056-A3B1E883-8537-4B50-BA98-DE57F0BD3454Q42008819-CE1AC712-FA20-4334-A7FD-D250F886F7A1Q42011183-97AF2926-0F77-46B5-8C1A-9D0EE08CF0A9Q42368547-3B6D9201-92FB-43C9-B218-A37EE338AB38Q42927681-64FE0FE0-F8CC-4BD4-A5F4-415B8F7E5428Q43162068-322B43A5-349E-411F-891F-84CC90411408Q43235164-DC1B5B43-F816-4DA4-8A9C-07690CDF964FQ43235313-E0CE739C-F66D-42E2-9C1B-6BA2C4EAAB45Q45107493-F4DE66D7-C1CE-48BE-A396-B099B98509E3Q45962507-76AC2CB3-AFEE-4AD5-91C8-4C7A02034AEAQ46159092-D853D9E6-490E-4BCE-9B49-08D824D826E4Q46208624-2B5A21D9-1122-446B-93E7-1CB9E6D73A31Q46712550-890E468D-6999-4EAE-B06B-4C95DA453D85Q46823901-0EA141D6-4A36-422B-94BE-46CAF6707D04Q48339828-99D603A2-0C00-4407-A6FC-E3B89452A307Q48391036-7533EE40-1B1D-4E57-B2FC-AEFB093F080EQ48391181-957423DA-4FC7-4E83-B5E2-98F4CFA2DA61Q48606887-1B13EB00-8057-45C4-BD86-8740B5387055Q48828855-4A7AAAF7-48F4-460B-901F-0EFEEE712B7AQ49119280-C410AFC1-8B4C-4612-9735-F40049F5EECCQ53689520-314D0A4A-6530-4BAD-B155-D7AA6060F01D
P50
description
researcher ORCID ID = 0000-0003-1373-4452
@en
name
Robert P Ostrowski
@ast
Robert P Ostrowski
@en
Robert P Ostrowski
@es
Robert P Ostrowski
@nl
type
label
Robert P Ostrowski
@ast
Robert P Ostrowski
@en
Robert P Ostrowski
@es
Robert P Ostrowski
@nl
prefLabel
Robert P Ostrowski
@ast
Robert P Ostrowski
@en
Robert P Ostrowski
@es
Robert P Ostrowski
@nl
P31
P496
0000-0003-1373-4452